Cite
HARVARD Citation
Yang, J. et al. (2021). Biosimilar pegfilgrastim may offer affordable treatment options for patients in France: a budget impact analysis on the basis of clinical trial and real-world data. Journal of medical economics. pp. 665-674. [Online].